Initiative for medicines access & knowledge
The Initiative for Medicines, Access, and Knowledge, known as I-MAK, is a U.S.-based global 501(c)(3) organization that advocates in the public interest for affordable access to medicines, and a medicines system that is more inclusive of patients and the public. I-MAK’s work has been featured in national and international media outlets, including The New York Times, The Wall Street Journal, The Financial Times, Fox Business, Bloomberg, the Washin… WebbThe EPS initiative is supported by three 'pillars', which have been identified as the initial key areas of focus for the pharmaceutical industry: Pillar 1 – IMI iPIE project: the identification of the potential environmental risks of existing and new active pharmaceutical ingredients (API) through intelligent and targeted assessment strategies.
Initiative for medicines access & knowledge
Did you know?
Webb8 sep. 2024 · Recognizing World Humanitarian Day 2024, the International Narcotics Control Board (INCB), the United Nations Office on Drugs and Crime (UNODC) and the World Health Organization (WHO) once again call on governments to facilitate access to medicines containing controlled substances in emergency settings, including during … Webb19 juni 2015 · The New York-based group, Initiative for Medicines, Access & Knowledge, or I-MAK, challenged Gilead’s patent application this year as part of its campaign to make generic Sovaldi available in ...
WebbFree and open company data on Michigan (US) company INITIATIVE FOR MEDICINES, ACCESS & KNOWLEDGE (I-MAK), INC (company number 802005393), 601 ABBOT ROAD EAST LANSING MI 48823. The Open Database Of The Corporate World. Search. Companies Officers Log in/Sign up; INITIATIVE FOR MEDICINES, ACCESS & … WebbRT @realtahiramin: Great op-ed. @pritikrishtel and @RSI’s Dr. Wayne Brough outline 3 reforms to course correct manipulation of the patent system: ↑ the bar for what gets patented, ↑ seats at the table for the public, ↓ costs for challenging patents.
WebbTahir Amin, LL.B., Dip. LP., is a founder and executive director of the Initiative for Medicines, Access & Knowledge (I-MAK), a nonprofit organisation working to address … WebbInitiative for Medicines, Access & Knowledge, Inc. Grant Information Purpose To support efforts to provide key stakeholders and policymakers nonpartisan technical …
Webb21 maj 2024 · The initiative will help create an enabling environment for local vaccines manufacturing in Africa and tackle barriers on both supply and demand sides, backed by €1 billion from the EU budget and the European development finance institutions such as the European Investment Bank (EIB).
WebbI-MAK is committed to creating inclusive connections between stakeholders in order to foster Participatory Changemaking. We believe that a more just and equitable … emr group houstonWebbThe Initiative for Medicines, Access & Knowledge 4 Followers A public interest non-profit of lawyers, scientists and health experts challenging the unmerited patents that … drays wholesaleWebbInitiative for Medicines Access & Knowledge. 2016. Annual Report. 2. ACRONYMS. A2M ACCESS TO MEDICINES ABC ABACAVIR SULFATE (ZIAGEN®) ARV … drays wholesale limitedWebbcal knowledge and does not deal specifically with associated genetic resources. 1 See WHO Fact Sheet N°134 “Traditional Medicine” (December 2008). 2 In particular, the Convention on Biological Diversity, the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization, and drayson \u0026 sons timber merchants ltdWebbGrants to Initiative for Medicines, Access & Knowledge, Inc. Amount. Purpose. Term. Source. $1,300,000. To support the purpose of developing and advancing a … drayss investments ltdWebb9 mars 2024 · The Initiative for Medicines, Access & Knowledge (I-MAK) has responded to a letter it received from Senator Thom Tillis (R-NC) in January asking the … drays road bowen for saleWebbITF briefing meetings provide a forum for early dialogue on medicines innovation. They cover regulatory, technical and scientific issues arising from innovative medicines … dray surname